|
ALB
|
hsa-miR-496 |
KEGG pathway |
Steroid hormone biosynthesis |
5.27E−08 |
|
hsa-miR-141-3p |
|
Hippo signaling pathway |
2.02E−05 |
|
|
|
Endocrine and other factor-regulated calcium reabsorption |
2.47E−05 |
|
|
GO terms |
Macromolecular complex assembly |
0.00030452 |
|
|
|
Epidermal growth factor receptor signaling pathway |
0.000423173 |
|
|
|
Post-translational protein modification |
0.000428322 |
|
|
|
G2/M transition of mitotic cell cycle |
0.000515818 |
|
|
|
Keratan sulfate biosynthetic process |
0.00053589 |
|
|
|
Fc-epsilon receptor signaling pathway |
0.000720702 |
|
|
|
Keratan sulfate metabolic process |
0.001811958 |
|
|
|
Sulfur compound metabolic process |
0.001941431 |
|
|
|
Phospholipid metabolic process |
0.005110673 |
|
|
|
ECM-receptor interaction |
1.46E−48 |
|
|
|
Mucin type O-glycan biosynthesis |
8.96E−09 |
|
|
KEGG pathway |
PI3K-Akt signaling pathway |
0.006961302 |
|
|
|
TNF signaling pathway |
0.009107875 |
|
|
|
Signaling pathways regulating pluripotency of stem cells |
0.009974988 |
|
COL1A2
|
hsa-miR-29c-3p |
GO terms |
Fc-epsilon receptor signaling pathway |
3.59E−17 |
|
hsa-let-7b-5p |
|
neurotrophin TRK receptor signaling pathway |
2.73E−15 |
|
hsa-let-7c-5p |
|
Extracellular matrix disassembly |
1.20E−12 |
|
hsa-let-7f-5p |
|
Post-translational protein modification |
3.56E−12 |
|
hsa-miR-29a-3p |
|
Extracellular matrix organization |
3.92E−09 |
|
|
|
Nucleobase-containing compound catabolic process |
8.99E−09 |
|
|
|
Platelet activation |
1.77E−08 |
|
COL3A1
|
hsa-miR-29c-3p |
KEGG pathway |
ECM-receptor interaction |
8.17E−49 |
|
hsa-miR-29a-3p |
|
Mucin type O-glycan biosynthesis |
7.54E−09 |
|
hsa-miR-29b-3p |
|
Focal adhesion |
0.001207023 |
|
hsa-miR-98-5p |
|
PI3K-Akt signaling pathway |
0.006207862 |
|
hsa-let-7b-5p |
GO terms |
Fc-epsilon receptor signaling pathway |
4.44E−17 |
|
|
|
Neurotrophin TRK receptor signaling pathway |
3.49E−15 |
|
|
|
Extracellular matrix disassembly |
1.42E−12 |
|
|
|
Post-translational protein modification |
4.28E−12 |
|
|
|
Cellular protein metabolic process |
1.98E−11 |
|
FN1
|
hsa-miR-200c-3p |
KEGG pathway |
Thyroid hormone signaling pathway |
0.024934027 |
|
hsa-miR-200b-3p |
|
Cysteine and methionine metabolism |
0.028989042 |
|
hsa-miR-429 |
|
Sphingolipid metabolism |
0.047606983 |
|
hsa-miR-199a-3p |
|
ErbB signaling pathway |
0.048121598 |
|
hsa-miR-144-3p |
GO terms |
Toll-like receptor TLR1:TLR2 signaling pathway |
0.010695034 |
|
|
|
Toll-like receptor TLR6:TLR2 signaling pathway |
0.010695034 |
|
|
|
Toll-like receptor 10 signaling pathway |
0.017791067 |
|
G6PC
|
hsa-miR-200c-3p |
KEGG pathway |
ECM-receptor interaction |
1.62E−70 |
|
hsa-miR-429 |
|
Focal adhesion |
3.49E−05 |
|
hsa-miR-200b-3p |
|
PI3K-Akt signaling pathway |
0.000700807 |
|
hsa-miR-3163 |
|
Signaling pathways regulating pluripotency of stem cells |
0.001671859 |
|
hsa-miR-29a-3p |
GO terms |
Cell death |
0.000888739 |
|
|
|
Fibroblast growth factor receptor signaling pathway |
0.001026574 |
|
|
|
Cellular lipid metabolic process |
0.0010844 |
|
|
|
MyD88-independent toll-like receptor signaling pathway |
0.001319258 |
|
PCK1
|
hsa-miR-1297 |
KEGG pathway |
Hippo signaling pathway |
0.000298106 |
|
hsa-miR-548m |
|
Thyroid hormone signaling pathway |
0.024032656 |
|
hsa-miR-330-3p |
|
Sphingolipid metabolism |
0.037579593 |
|
hsa-miR-101-3p |
|
Adherens junction |
0.037579593 |
|
hsa-miR-3163 |
GO terms |
Cellular component disassembly involved in execution phase of apoptosis |
3.19E−05 |
|
|
|
Cell proliferation |
0.000266671 |
|
|
|
Cellular protein metabolic process |
0.000394966 |
|
|
|
Macromolecular complex assembly |
0.00042068 |
|
|
|
Fc-epsilon receptor signaling pathway |
0.000562009 |
|
|
|
Response to stress |
0.000562009 |
